scholarly journals Pathogenesis, clinical features, and treatments of depression in Parkinson's disease

2019 ◽  
Vol 11 (2) ◽  
pp. 93-99 ◽  
Author(s):  
I. V. Milyukhina

Depression is the most common non-motor manifestation of Parkinson's disease (PD), which significantly affects the rate of disease progression and increases the risk of motor complications and dementia. The paper considers the etiology and pathogenesis, cause-and-effect factors of depression in PD, and features of its diagnosis and treatment. Attention is paid to the algorithm for a physician's actions in the detection of depressive disorder in a patient with PD, to the choice of an antidepressant, and to the promising areas of therapy.

2015 ◽  
Vol 14 (5) ◽  
pp. 518-531 ◽  
Author(s):  
Javier Pagonabarraga ◽  
Jaime Kulisevsky ◽  
Antonio P Strafella ◽  
Paul Krack

1994 ◽  
Vol 6 (2) ◽  
pp. 29-33
Author(s):  
E.CH. Wolters ◽  
G. Tissingh ◽  
M.A. Kuiper ◽  
W.A. Zwaan ◽  
M.W.I.M. Horstink

SummaryIn this first part of a review on drug-induced psychosis in Parkinson's disease, the etiology, the clinical features and the therapeutic strategies will be discussed. The drugs used in the therapy of Parkinson's disease may lead to non-motor complications, such as delirium or hallucinations. Especially anti-cholinergics, respectivily dopaminometics, play an important role. Lowering the dose or even discontinuing the medication is the main therapeutic measure. The use of an atypical antipsychotic drug (clozapine) may be indicated.


2008 ◽  
Vol 14 (5) ◽  
pp. 431-435 ◽  
Author(s):  
Leslie W. Ferguson ◽  
Michele L. Rajput ◽  
Nazeem Muhajarine ◽  
Syed M. Shah ◽  
Alexander Rajput

2021 ◽  
Vol 81 ◽  
pp. 307-311 ◽  
Author(s):  
Claudio Liguori ◽  
Valentino De Franco ◽  
Rocco Cerroni ◽  
Matteo Spanetta ◽  
Nicola Biagio Mercuri ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document